These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21051997)

  • 21. An improved fluorescence polarization assay in 5'-nuclease reaction for gene promoter methylation detection.
    Su H; Wu Z; Wang Y; Jiang Y; Qiang S; Cheng H; Liu W; Zhang J
    J Biotechnol; 2015 Oct; 211():81-6. PubMed ID: 26197420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of DNA methylation in the promoter region of the methylguanine-O(6) -DNA-methyltransferase gene by COBRA and subsequent native capillary gel electrophoresis.
    Goedecke S; Mühlisch J; Hempel G; Frühwald MC; Wünsch B
    Electrophoresis; 2015 Dec; 36(23):2939-50. PubMed ID: 26331436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of ERCC1 118 polymorphisms in non-small-cell lung cancer by an improved fluorescence polarization assay.
    Wenchao L; Xiaohui L; Yan X; Helong Z; Wenzhao Y; Yanhai G; Zhen Y; Ju Z
    Diagn Mol Pathol; 2010 Sep; 19(3):164-8. PubMed ID: 20736746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is significantly less frequent in ependymal tumours as compared to malignant astrocytic gliomas.
    Koos B; Peetz-Dienhart S; Riesmeier B; Frühwald MC; Hasselblatt M
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):356-8. PubMed ID: 20202118
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.
    Yin D; Xie D; Hofmann WK; Zhang W; Asotra K; Wong R; Black KL; Koeffler HP
    Mol Carcinog; 2003 Jan; 36(1):23-31. PubMed ID: 12503076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The correlation between promoter methylation status and the expression level of O6-methylguanine-DNA methyltransferase in recurrent glioma.
    Suzuki T; Nakada M; Yoshida Y; Nambu E; Furuyama N; Kita D; Hayashi Y; Hayashi Y; Hamada J
    Jpn J Clin Oncol; 2011 Feb; 41(2):190-6. PubMed ID: 21148162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
    Wojdacz TK; Dobrovic A
    Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
    Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism.
    Candiloro IL; Dobrovic A
    Cancer Prev Res (Phila); 2009 Oct; 2(10):862-7. PubMed ID: 19789298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
    Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.
    Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T
    Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
    Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC
    Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between response to primary treatments and MGMT status in glioblastoma.
    Franceschi E; Tosoni A; Pozzati E; Brandes AA
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
    Hermes M; Geisler H; Osswald H; Riehle R; Kloor D
    Biochem Pharmacol; 2008 Jun; 75(11):2100-11. PubMed ID: 18395186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.
    Vlassenbroeck I; Califice S; Diserens AC; Migliavacca E; Straub J; Di Stefano I; Moreau F; Hamou MF; Renard I; Delorenzi M; Flamion B; DiGuiseppi J; Bierau K; Hegi ME
    J Mol Diagn; 2008 Jul; 10(4):332-7. PubMed ID: 18556773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatitis B virus genotypes A to D by the fluorescence polarization assay based on asymmetric PCR.
    Ding L; Rui C; Zhansheng J; Xiangling W; Ping L; Zhen Y; Yanhai G; Ju Z
    J Virol Methods; 2010 Sep; 168(1-2):31-7. PubMed ID: 20406657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.